Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Chiasma
$55,900,000
Follow-OnCo-Manager
July 2019
RiverNorth Managed Duration Municipal Income Fund
$365,000,000
IPOCo-Manager
July 2019
Relmada Therapeutics
$8,000,000
PIPECo-Placement Agent
June 2019
Atreca
$143,700,000
IPOCo-Manager
June 2019
Hepion Pharmaceuticals
$15,600,000
Follow-OnCo-Placement Agent
June 2019
BlackRock Science and Technology Trust II
$1,400,000,000
IPOCo-Manager
June 2019
Cellectar Biosciences
$10,000,000
Registered Direct & PIPEFinancial Advisor
May 2019
Angel Oak Financial Strategies Income Trust
$215,000,000
IPOCo-Manager
May 2019
Hepion Pharmaceuticals
$2,100,000
Follow-OnCo-Placement Agent
April 2019
Vaxart
$9,300,000
Follow-OnCo-Manager
April 2019
Bioceres / Union Acquisition Corp.
$485,000,000
MergerM&A Advisor
March 2019
Chiasma
$34,500,000
Follow-OnCo-Manager
March 2019
8i Enterprises Acquisition Corp.
$57,500,000
IPOCo-Manager
March 2019
Vaxart
$3,000,000
Registered DirectCo-Placement Agent
March 2019
Tortoise Essential Assets Income Term Fund
$260,000,000
IPOCo-Manager
March 2019
Geneos Therapeutics
$5,000,000
Series B Convertible Preferred StockSole Placement Agent
February 2019
Applied Therapeutics
$25,000,000
Series B Convertible Preferred StockExclusive Placement Agent
February 2019
Wealthbridge Acquisition
$57,500,000
IPOCo-Manager
February 2019
Peerbridge Health
$5,700,000
Series C Convertible NoteCo-Placement Agent
January 2019
Rezolute
$25,000,000
PIPEFinancial Advisor
January 2019
Rexahn Pharmaceuticals
$8,600,000
Follow-OnCo-Manager
January 2019
PIMCO Energy & Tactical Credit Opportunities Fund
$850,000,000
IPOCo-Manager
January 2019
Chardan Healthcare Acquisition Corp.
$70,000,000
IPOCo-Manager
December 2018
Histogenics
$17,000,000
Follow-OnFinancial Advisor
November 2018